Cargando…

PB1984: FACTORS ASSOCIATED WITH PROGRESSION-FREE SURVIVAL IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020

Detalles Bibliográficos
Autores principales:	Gamboa, Néstor, Peña, Ángela María, Salazar, Luis Antonio, Vesga-Jerez, Gabriela, Prada-Sepúlveda, Ana María, Luna-González, María, Ochoa, Miguel, Sossa, Claudia Lucía, Abello, Virgnia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2023
Materias:	Publication Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430051/ http://dx.doi.org/10.1097/01.HS9.0000974752.18215.9e

Ejemplares similares

PB1985: FACTORS ASSOCIATED WITH TOLERANCE TO PHARMACOLOGICAL THERAPY USING TYROSINE KINASE INHIBITORS IN CHRONIC MYELOID LEUKEMIA PATIENTS ATTENDED AT FOSCAL IN THE PERIOD 2013-2020.
por: Sossa, Claudia Lucía, et al.
Publicado: (2023)

PB1845: ACUTE MYELOID LEUKEMIA IN THE ELDERLY: A MULTICENTER EXPERIENCE IN COLOMBIA, ON BEHALF OF ACHO’S RENEHOC INVESTIGATORS
por: Sossa-Melo, C., et al.
Publicado: (2022)

PB1870: FACTORS ASSOCIATED WITH OVERALL SURVIVAL IN ACUTE MYELOID LEUKEMIA: RENEHOC REGISTRY STUDY.
por: Sossa, Claudia Lucía, et al.
Publicado: (2023)

PB1978: AUTOLOGOUS STEM CELL TRANSPLANTATION AND MAINTENANCE IMPROVES SURVIVAL, IN COLOMBIAN MULTIPLE MYELOMA PATIENTS. ACHO’S RENEHOC REGISTRY REPORT
por: Abello, V., et al.
Publicado: (2022)

PB2013: THE FREQUENCY, EVOLUTION AND SIGNIFICANCE OF GENE MUTATION IN MYELODYSPLASTIC SYNDROMES WITH NORMAL KARYOTYPE
por: Xu, Feng, et al.
Publicado: (2023)

PB1918: MOLECULAR CHARACTERIZATION AND CLINICAL RELEVANCE OF ERYTHROPOIESIS IN MIELODYSPLASTIC SYNDROMES.
por: Villalba, A., et al.
Publicado: (2022)

PB1984: ELOTUZUMAB PLUS LENALIDOMIDE AND DEXAMETHASONE IN RELAPSED/REFRACTORY MULTIPLE MYELOMA: EXTENDED 3-YEAR FOLLOW-UP OF AN ITALIAN, MULTICENTER, EXPERIENCE OUTSIDE OF CONTROLLED CLINICAL TRIALS
por: Bruzzese, A., et al.
Publicado: (2022)

PB2013: TECLISTAMAB COMPARED WITH REAL-WORLD THERAPIES IN PATIENTS WITH TRIPLE-CLASS EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Krishnan, A., et al.
Publicado: (2022)

PB2049: MEXICAN REGISTRY OF MYELOPROLIFERATIVE NEOPLASMS. INITIAL REPORT
por: De La Peña Celaya, J. A., et al.
Publicado: (2022)

Ciguatera in Mexico (1984–2013)
por: Núñez-Vázquez, Erick J., et al.
Publicado: (2018)

PB2353: PROGNOSTIC VALUE OF TIME FROM SYMPTOMS BEGIN TO START TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA
por: Lakhwani, Sunil Lakhwani, et al.
Publicado: (2023)

PB2539: GEOGRAPHICAL PREVALENCE OF THALASSEMIA GENE MUTATION IN THE PHILIPPINES
por: Velasco, Manuel Jr, et al.
Publicado: (2023)

PB1748: LOW HAIR CORTISOL CONCETRANTIONS AT DIAGNOSIS OF CHILDHOOHD HEMATOLOGICAL MALIGNANCIES
por: Kourou, Panagiota, et al.
Publicado: (2023)

PB2323: R-ESHAP VS R-ICE AS RESCUE TREATMENT IN DIFFUSE LARGE B-CELL LYMPHOMA. A SINGLE-CENTEREXPERIENCE.
por: Pérez-Pinilla, Belén, et al.
Publicado: (2023)

PB2549: CO-EXISTENT COLD AGGLUTININ DISEASE AND CRYOGLOBULINAEMIA
por: Japzon, Nicole, et al.
Publicado: (2023)

PB2599: THE FREQUENCY OF PHENOTYPES OF THE MNS, KIDD, DUFFY SYSTEMS IN PATIENTS OF THE HEMATOLOGY CLINIC
por: Yovdiy, Anna, et al.
Publicado: (2023)

PB2383: MICROSATELLITE INSTABILITY AND 9P24.1 ALTERATIONS IN HODGKIN LYMPHOMA
por: Tregubova, Ekaterina, et al.
Publicado: (2023)

PB1911: CYTOGENOMIC INTEGRATIVE ANALYSIS OF CLL/SLL PATIENTS AT DISEASE PROGRESSION.
por: García-Serra, Rocío, et al.
Publicado: (2023)

PB2382: EFFECTS OF ANTIFASCIN COMPOUNDS AGAINST LYMPHOMA CELLS IN VITRO
por: María Hurtado López, Ana, et al.
Publicado: (2023)

PB2314: CYTOPENIAS AND BLOOD TRANSFUSION SUPPORT AFTER CAR-T THERAPY
por: Rivada, Marcos, et al.
Publicado: (2023)

PB1712: LYOPHILIZATION BASED ISOLATION OF EXOSOMES FOR DELIVERY OF DRUGS AND PROTEIN
por: Rehman, Fawad Ur, et al.
Publicado: (2023)

PB2392: MRNA IDENTIFICATION OF TIGIT IN PERITUMORAL LYMPHOCYTES IN CLASSICAL HODGKIN DISEASE
por: Annibali, Ombretta, et al.
Publicado: (2023)

PB2030: HYPERCHROMIC ANEMIA AS THE FIRST MANIFESTATION OF MYELOPROLIFERATIVE DISEASE
por: Lepkov, Sergey, et al.
Publicado: (2023)

PB1817: THE ADDITION OF ZALCITABINE TO ACUTE MYELOID LEUKEMIA TREATMENT MAY IMPROVE AZACITIDINE AND VENETOCLAX COMBINATION
por: Sofía, Álvarez-Galeano, et al.
Publicado: (2023)

PB1812: CO-MUTATION PROFILE IN A REAL-LIFE COHORT OF ACUTE MYELOID LEUKEMIA (AML)
por: Piras, Giovanna, et al.
Publicado: (2023)

PB2345: MOGAMULIZUMAB IN MYCOSIS FUNGOIDES AND SÈZARY SYNDROME: AN ITALIAN SINGLE CENTER EXPERIENCE
por: Simula, Maria Pina, et al.
Publicado: (2023)

PB2577: INFECTIONS AND THEIR RELATIONSHIP WITH EARLY MORTALITY IN PATIENTS NEWLY DIAGNOSED WITH MULTIPLE MYELOMA
por: Ontiveros-Austria, Juan Luis, et al.
Publicado: (2023)

PB2351: ANXIETY AT THE HEMATOLOGIST
por: Trojan, S., et al.
Publicado: (2022)

PB1952: CLL IN AYA
por: Mohamed, Shehab, et al.
Publicado: (2023)

PB2126: RETROSPECTIVE REAL LIFE STUDY OF MULTIPLE MYELOMA STATUS AT DEATH.
por: Pérez, Mónica Fernández, et al.
Publicado: (2023)

PB1971: FREQUENCY AND CHARACTERISTICS OF DEL(6Q) IN PATIENTS WITH MULTIPLE MYELOMA FROM LATIN-AMERICAN COUNTRIES. A REAL-WORLD STUDY
por: Stella, F., et al.
Publicado: (2022)

PB2364: DEMOGRAPHICS, PATTERN OF CARE, AND OUTCOMES OF PRIMARY NODAL PERIPHERAL T-CELL LYMPHOMAS. DATA FROM THE MOLDOVAN HEMATOLOGICAL CENTER.
por: Tomacinschii, Victor, et al.
Publicado: (2023)

PB2532: VARIABLE HEMATOLOGICAL AND CLINICAL PHENOTYPES IN DOUBLE HETEROZYGOTES OF ΒETA-THALASSEMIA AND TRIPLICATED ΑLPHA-GLOBIN GENES
por: Delaporta, Polyxeni, et al.
Publicado: (2023)

PB2127: REAL-WORLD EFFECTIVENESS AND SAFETY OF BELANTAMAB MAFODOTIN IN TRIPLE CLASS REFRACTORY PATIENTS WITH MULTIPLE MYELOMA
por: Ntanasis-Stathopoulos, Ioannis, et al.
Publicado: (2023)

PB1754: HOMOZYGOUS DELETION OF ETV6: EARLY T-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA OR PRECURSOR T-LYMPHOBLASTIC LYMPHOMA
por: Álvarez, Miguel Ángel Perera, et al.
Publicado: (2023)

PB1839: INDEPENDENT PROGNOSTIC VALUE OF A PLATELET COUNT OVER 300X109/L IN ACUTE MYELOBLASTIC LEUKEMIA PATIENTS TREATED WITH AN INTENSIVE REGIMEN.
por: Ródenas Quiñonero, I., et al.
Publicado: (2022)

PB2124: EFFICACY AND IMMUNE MODULATION OF DARATUMUMAB PLUS IMID COMBINATION IN PATIENTS REFRACTORY TO BOTH AGENTS“
por: Kostopoulos, Ioannis, et al.
Publicado: (2023)

PB2585: IS THROMBOCYTOPENIA WITH INCREASED IMMATURE PLATELET FRACTION [IPF] IN ICU PATIENTS,A BAD PROGNOSIS?
por: Lourenco, Enna Maria, et al.
Publicado: (2023)

PB1719: NIRAPARIB IN B-CELL LYMPHOID MALIGNANCIES: EXPLORING SYNTHETIC LETHALITY AS TARGET FOR THERAPY
por: Lapa, Beatriz, et al.
Publicado: (2023)

PB2398: BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA IN 2 CENTERS OF BOGOTÁ – COLOMBIA: THE LARGEST CASE SERIES IN LATIN AMERICA
por: Cynthia Fuentes-Lacouture, Maria, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_gqb2ig949lpr4d56qo2fmqh4f1